Apexigen

Apexigen

Apexigen

Apexigen is a biopharmaceutical product development company developing products to address life-threatening and difficult to treat diseases.
Raised
$15M
Follow us
Alexa global traffic share
Latest funding
$15,000,000
Venture capital (Series B) - 2018
Decheng Capital
Team Size
1–10
Employees
FinSMEs

Apexigen Closes $123M Series C Financing Round

FinSMEs

Apexigen Raises $73M in Series B And Series C Financings

Health Funding